EP13.07. Efficacy and Safety of Antiangiogenic Therapy plus Immunotherapy as Later-line Treatment for Small Cell Lung Cancer - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yutao Liu
Meta Tag
Speaker Yutao Liu
Topic SCLC & Neuroendocrine Tumors: Relapse & Salvage Therapy
anti-angiogenic therapy
immune checkpoint inhibitors
small cell lung cancer
retrospective analysis
progression-free survival
disease control rate
adverse reactions
therapy option
Powered By